BioCryst Pharmaceuticals | 债务利息支出

Interest Expense On Debt 更改 日
Alnylam Pharmaceuticals USD 31.34M 445K 2023-12
Gilead Sciences USD 252M 20M 2023-12
Ionis Pharmaceuticals USD 4.56M 355K 2023-12
Neurocrine Biosciences USD 1.1M 200K 2023-09
Regeneron Pharmaceuticals USD 18.3M 500K 2023-12
Roche Holding CHF 401M 53M 2023-06
Sarepta Therapeutics USD 5.23M 5K 2023-09
Vertex Pharmaceuticals USD 10.9M 300K 2023-09



BioCryst Pharmaceuticals 债务利息支出 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.